Clinical trial
Efficacy and Safety of Oxymorphone Extended Release in Opioid-Experienced…
NCT00226421 · Endo Pharmaceuticals, Industry · Completed
Key facts
| NCT number | NCT00226421 |
|---|---|
| Title | Efficacy and Safety of Oxymorphone Extended Release in Opioid-Experienced Patients With Chronic Non-Malignant Pain |
| Official title | An Open-Label Titration Followed by a Randomized, Double-Blind, Placebo-Controlled Study to Assess the Efficacy, Tolerability, and Safety of Oxymorphone Extended Release Tablets in Opioid-Experienced Patients With Chronic Low Back Pain |
| Lead sponsor | Endo Pharmaceuticals, Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Chronic Pain |
| Intervention type | Drug |
| Interventions | Oxymorphone Extended Release |
| Enrollment | 120 |
| Start date | Oct 1, 2004 |
| Completion | Aug 1, 2005 |
| First posted | Sep 27, 2005 |
| Last update posted | Jan 2, 2024 |
| Countries | United States |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: